Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis

Michael W. Konstan, Jeffrey S. Wagener, David J. Pasta, Stefanie J. Millar, Wayne J. Morgan

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences